A examine published in JAMA Network Open up emphasizes the discrepancy between what it charges to create copyright along with the retail rates patients encounter. Despite the reduced generation expenditures, Novo Nordisk hasn't publicly disclosed precise figures for copyright or its other product, Wegovy.In October 2024, Novo Nordisk printed a stud